Skip to content
2000
Volume 21, Issue 19
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background

Significant research efforts have been directed towards developing systems for enhancing the intracellular delivery of phosphate-substituted compounds, such as biologically active peptides and nucleotides. Phosphoramidates (P-N) are organophosphorus structures containing a single covalent bond between the P(V) and N(III) atoms. Three types of phosphoroamidates are discovered. Organophosphorus compounds, defined as (RO)2P(O)NR’2 (R, R’ = H, alkyl, aryl, heteroaryl), is a stable phosphoryl bond (P=O). Novel phosphoramidate derivatives of hydroxy functional or amino functional compounds include peptides, peptidomimetics and nucleotide analogs. The compounds enable enhanced intracellular delivery of drugs as their corresponding phosphate esters or amides. phosphoramidates exhibit antiproliferative activity and could be used for the treatment of cancers. Phosphoramidates exhibit potential applications in the field of biomedicine as antiviral, anti-HIV, antimalarial and anticancer agents.

Objective

A computer-aided investigation compared these new compounds to , assessing potential pharmacological properties.

Methods

An efficient microwave method was used to synthesize novel N-arylphosphoramidates from commercially available nitroarenes using trialkyl phosphites.

Results

Novel N-arylphosphoramidates are prepared with good yields and reduced reaction times. NMR spectroscopy (HH-COSY, HSQC, HMBC) elucidated their structures.

Conclusion

A practical reductive domino reaction involving a trialkyl phosphite under microwave irradiation has been developed to convert nitroarenes into dialkyl N-arylphosphoramidates. The comparative study conducted in this research effectively ranked compounds concerning approved medications (), providing a solid foundation for further investigation. Molecular docking analysis of our 15 ligands and revealed several similarities. This indicates that , an approved drug, and our ligands have comparable binding affinities for the primary protease (PDB code 7BQY). Such insights encourage us for further exploration and optimization of their potential therapeutic applications as COVID-19 inhibitors. Molecular docking studies examined these compounds as COVID-19 inhibitors based on their interactions and binding affinities for the SARS-CoV-2 main protease (PDB code 7BQY).

Loading

Article metrics loading...

/content/journals/lddd/10.2174/0115701808352074241230111321
2024-12-31
2025-09-01
Loading full text...

Full text loading...

References

  1. PetkowskiJ.J. BainsW. SeagerS. Natural products containing ‘Rare’ organophosphorus functional groups.Molecules201924586610.3390/molecules24050866 30823503
    [Google Scholar]
  2. SzliszkaE. CzubaZ.P. DominoM. MazurB. ZydowiczG. KrolW. Ethanolic Extract of Propolis (EEP) enhances the apoptosis- inducing potential of TRAIL in cancer cells.Molecules200914273875410.3390/molecules14020738
    [Google Scholar]
  3. ClareC.E. BrassingtonA.H. KwongW.Y. SinclairK.D. One-carbon metabolism: Linking nutritional biochemistry to epigenetic programming of long-term development.Annu. Rev. Anim. Biosci.20197126328710.1146/annurev‑animal‑020518‑115206 30412672
    [Google Scholar]
  4. BesantP. AttwoodP. PiggottM. Focus on phosphoarginine and phospholysine.Curr. Protein Pept. Sci.200910653655010.2174/138920309789630598 19751195
    [Google Scholar]
  5. MoriguchiT. AsaiN. WadaT. SekineM. Synthesis of nucleotide antibiotics having N-acyl phosphoramidate linkages.Nucleic Acids Symposium. Series1999421151610.1093/nass/42.1.15
    [Google Scholar]
  6. CaoY. DengQ. DaiS. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.Travel Med. Infect. Dis.20203510164710.1016/j.tmaid.2020.101647 32247927
    [Google Scholar]
  7. NguyenT.M. ChangS. CondonB. SlopekR. GravesE. Yoshioka-TarverM. Structural effect of phosphoramidate derivatives on the thermal and flame retardant behaviors of treated cotton cellulose.Ind. Eng. Chem. Res.201352134715472410.1021/ie400180f
    [Google Scholar]
  8. XieX. QinZ. HeY. XiongP. HuangZ. MaoY. WeiH. ZhuoL. Significant enhanced uranyl ions extraction efficiency with phosphoramidate-functionalized ionic liquids via synergistic effect of coordination and hydrogen bond.Sci. Rep.2017711573510.1038/s41598‑017‑15899‑0 29146928
    [Google Scholar]
  9. JiQ. GeZ. GeZ. ChenK. WuH. LiuX. HuangY. YuanL. YangX. LiaoF. Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents.Eur. J. Med. Chem.201610816617610.1016/j.ejmech.2015.11.027 26647304
    [Google Scholar]
  10. McGuiganC. ThieryJ.C. DaverioF. JiangW.G. DaviesG. MasonM. Anti-cancer ProTides: Tuning the activity of BVDU phosphoramidates related to thymectacin.Bioorg. Med. Chem.20051393219322710.1016/j.bmc.2005.02.041 15809157
    [Google Scholar]
  11. OkonA. Matos de SouzaM.R. ShahR. AmorimR. da CostaL.J. WagnerC.R. Anchimerically activatable antiviral protides.ACS Med. Chem. Lett.20178995896210.1021/acsmedchemlett.7b00277 28947944
    [Google Scholar]
  12. SlusarczykM. SerpiM. PertusatiF. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.Antivir. Chem. Chemother.201826204020661877524310.1177/2040206618775243 29792071
    [Google Scholar]
  13. MaraC. DempseyE. BellA. BarlowJ.W. Synthesis and evaluation of phosphoramidate and phosphorothioamidate analogues of amiprophos methyl as potential antimalarial agents.Bioorg. Med. Chem. Lett.201121206180618310.1016/j.bmcl.2011.07.088 21889338
    [Google Scholar]
  14. LiX. FuH. JiangY. ZhaoY. LiuJ. New and efficient approach to aryl phosphoramidate derivatives of AZT/d4T as anti-HIV prodrugs.Synlett20042004142600260210.1055/s‑2004‑834800
    [Google Scholar]
  15. VenkatachalamT.K. SamuelP. QaziS. UckunF.M. Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives.Bioorg. Med. Chem.200513185408542310.1016/j.bmc.2005.04.083 15994083
    [Google Scholar]
  16. YadavL.D.S. SrivastavaV.P. PatelR. The first application of the Baylis–Hillman reaction in azetidine chemistry: A convenient synthesis of azetidine-3-carbonitriles/carboxylates.Tetrahedron Lett.200849395652565410.1016/j.tetlet.2008.07.069
    [Google Scholar]
  17. YadavL.D.S. RaiA. RaiV.K. AwasthiC. Novel aziridination of α-halo ketones: An efficient nucleophile-induced cyclization of phosphoramidates to functionalized aziridines.Tetrahedron Lett.200849468769010.1016/j.tetlet.2007.11.130
    [Google Scholar]
  18. YadavL.D.S. AwasthiC. RaiV.K. RaiA. A convenient synthesis of 1,2,4-trisubstituted azetidines by reductive cyclization of aza-Michael adducts of chalcones.Tetrahedron Lett.200748458037803910.1016/j.tetlet.2007.09.044
    [Google Scholar]
  19. AthertonF.R. OpenshawH.T. ToddA.R. 174. Studies on phosphorylation. Part II. The reaction of dialkyl phosphites with polyhalogen compounds in presence of bases. A new method for the phosphorylation of amines.J. Chem. Soc.194566066310.1039/jr9450000660
    [Google Scholar]
  20. ZwierzakA. OsowskaK. A convenient method for the protection of amino groups as diethyl phosphoramidates.Synthesis19841984322322410.1055/s‑1984‑30778
    [Google Scholar]
  21. CadoganJ.I.G. Reduction of nitro- and nitroso-compounds by tervalent phosphorus reagents.Q. Rev. Chem. Soc.196822222225110.1039/qr9682200222
    [Google Scholar]
  22. CadoganJ.I.G. MarshallR. SmithD.M. ToddM.J. Reduction of nitro- and nitroso-compounds by tervalent phosphorus reagents. Part VIII. Syntheses of benzimidazoles and anthranils.J. Chem. Soc. C1970182441244310.1039/j39700002441
    [Google Scholar]
  23. SundbergR.J. Indoles from o-Nitrostyrenes.J. Org. Chem.196530113604361010.1021/jo01022a006
    [Google Scholar]
  24. SundbergR.J. DasB.P. SmithR.H. Photochemical deoxygenation of aromatic nitro compounds in triethyl phosphite. Substituent effects and evidence for the involvement aryl nitrenes.J. Am. Chem. Soc.196991365866810.1021/ja01031a024
    [Google Scholar]
  25. HaggamR. ConradJ. BeifussU. Practical and reliable synthesis of dialkyl N-arylphosphoramidates with nitroarenes as substrates.Tetrahedron Lett.200950486627663010.1016/j.tetlet.2009.09.037
    [Google Scholar]
  26. SaidM.A. MessaliM. RezkiN. Al-SoudY.A. AouadM.R. Green microwave versus conventional synthesis, crystal structure of 1-(4-(Benzothiazol-2-yl)piperazin-1-yl)-2-(4-phenyl-1 H -1,2,3-triazol-1-yl)ethenone and HS-Analysis.J. Taibah Univ. Sci.202014154955610.1080/16583655.2020.1751977
    [Google Scholar]
  27. SaidM.A. Al-HarbiW.S. ShanmugamM. AljohaniF.S. BouqellahN.A. Al-KaffN.S. SynthesisX.R.D. Synthesis, XRD, HAS, in silico molecular docking studies and biological assessment of novel Schiff base compounds as anti-cancer and antimicrobial agents.J. Taibah Univ. Sci.20201411590160310.1080/16583655.2020.1849492
    [Google Scholar]
  28. AlharbiR.A.K. RiyadhS.M. Al-KaffN.S. SaidM.A. Newly synthesized Bis-Hydrazono[1,3,4] thiadiazoles as Anti-Alzheimer’s Agents: Greener past and In-Vitro acetylcholinesterase inhibition assay investigations.J. Saudi Chem. Soc.202428310186810.1016/j.jscs.2024.101868
    [Google Scholar]
  29. DabkowskiW. MichalskiJ. RadziejewskiC. SkrzypczyńskiZ. Phosphoric and phosphinic sulfonic anhydrides – reinvestigation and corrections. Novel methods of synthesis.Chem. Ber.198211541636164310.1002/cber.19821150438
    [Google Scholar]
  30. JieZ. RammoortyV. FischerB. Diethyl chlorophosphite: A versatile reagent.J. Org. Chem.200267371171910.1021/jo0106851 11856010
    [Google Scholar]
  31. CadoganJ.I.G. SearsD.J. SmithD.M. ToddM.J. Reduction of nitro- and nitroso-compounds by tervalent phosphorus reagents. Part V. Reduction of alkyl- and methoxy-nitrobenzenes, and nitrobenzene by trialkyl phosphites.J. Chem. Soc. C19692813281910.1039/j39690002813
    [Google Scholar]
  32. WuZ. HanZ. LiuB. ShenN. Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials.Front. Pharmacol.20221397189010.3389/fphar.2022.971890 36160434
    [Google Scholar]
  33. PanD. OdorizziP. SchoenichenA. AbdelghanyM. ChenS. OsinusiA. PattersonS.D. DownieB. JunejaK. WallinJ.J. Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting.Commun. Med.2023310.1038/s43856‑022‑00232‑2
    [Google Scholar]
  34. Al GaradiW. SaidM.A. DemirtaşG. Al-KaffN.S. MagueJ.T. EssassiE.M. RamliY. Indapamide analogue a promising drug: Synthesis, a novel crystal structure, HSA/DFT/XRD, greener pastures biological study.J. Mol. Struct.2024129513659310.1016/j.molstruc.2023.136593
    [Google Scholar]
  35. Abu-DiefA.M. SaidM.A. ElhadyO. AlahmadiN. AlzahraniS. Designing of some novel Pd(II), Ni(II) and Fe(III) complexes: Synthesis, structural elucidation, biomedical applications, DFT and docking approaches against Covid-19.Inorg. Chem. Commun.202315511095510.1016/j.inoche.2023.110955
    [Google Scholar]
  36. Abu-DiefA.M. SaidM.A. ElhadyO. Al-AbdulkarimH.A. AlzahraniS. EskanderT.N.A. El-RemailyM.A.E.A.A.A. Innovation of Fe(III), Ni(II), and Pd(II) complexes derived from benzothiazole imidazolidin‐4‐ol ligand: Geometrical elucidation, theoretical calculation, and pharmaceutical studies.Appl. Organomet. Chem.2023378e716210.1002/aoc.7162
    [Google Scholar]
/content/journals/lddd/10.2174/0115701808352074241230111321
Loading
/content/journals/lddd/10.2174/0115701808352074241230111321
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test